| NCT ID | NCT05562180 |
| Status | Recruiting |
| Phase | Phase 2, Phase 3 |
| Sponsor | Kaiser Permanente |
| Condition | Diet, Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-04-08 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 30 participants in total. It began in 2024-04-08 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will develop and test and app that will create meal plans to improve diet quality and support weight loss. This app will allow participants to customize their meal plans and substitute recipes for nutritionally equivalent options that they find more appealing, thus potentially increasing adherence.
Eligibility Criteria
Inclusion Criteria: Already enrolled in FoodRx study \>18 years BMI\>27 and wants to lose weight - Exclusion Criteria: Not enrolled in Food Rx \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05562180 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diet, Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT05562180 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT05562180 currently recruiting?
Yes, NCT05562180 is actively recruiting participants. Contact the research team at kelly.e.lopez@kp.org for enrollment information.
Where is the NCT05562180 trial being conducted?
This trial is being conducted at Pasadena, United States.
Who is sponsoring the NCT05562180 clinical trial?
NCT05562180 is sponsored by Kaiser Permanente. The trial plans to enroll 30 participants.